Modeling Principle

The Beagle Asthma Model is a standardized SCI-recognized large-animal model in translational respiratory medicine, allergic asthma mechanism research, airway inflammation and airway remodeling, as well as preclinical development of novel anti-asthmatic drugs and airway-targeted agents. Adopting the classic modeling strategy of systemic sensitization combined with local airway challenge, gradient stimulation with allergens such as ovalbumin (OVA) and house dust mite (HDM) induces specific immune responses in Beagle dogs, simulating the dual pathological characteristics of immediate hypersensitivity and delayed chronic airway inflammation in clinical allergic asthma. Relying on the highly homologous biological advantages of Beagle dogs in respiratory tract anatomy, airway epithelial barrier structure, airway smooth muscle distribution, pulmonary ventilation and gas exchange pattern, immune cell typing, inflammatory cytokine secretion profile, and temporal law of airway remodeling, this model faithfully recapitulates the whole process of human bronchial asthma, including airway hyperresponsiveness, eosinophilic infiltration, airway mucus hypersecretion, airway wall thickening, collagen deposition and irreversible airway remodeling. Compared with rodent models, Beagle dogs have airway diameter, pulmonary lobe segmentation, respiratory rhythm and immune regulation mechanisms closer to humans, avoiding experimental deviation caused by species-specific immune differences in small animals. It supports repeated airway challenge, multiple pulmonary function tests, airway lavage and in vivo tissue sampling, with significantly superior experimental repeatability and data stability. Standardized sensitization, challenge, intervention and detection procedures yield low intra-group data dispersion, fully meeting the experimental standards of high-impact respiratory SCI journals, National Natural Science Foundation projects and postgraduate dissertations. This model is widely adopted for preclinical efficacy and biosafety evaluation of asthma anti-inflammatory targeted drugs, airway protective agents, aerosol delivery systems, gene intervention, stem cell therapy and anti-remodeling strategies.

Modeling Success Criteria

Quantitative Functional Criteria

Pulmonary function detection after modeling shows that the model group presents significantly increased airway resistance, significantly decreased lung compliance and stable airway hyperresponsiveness; typical asthmatic respiratory phenotypes are observed including recurrent wheezing, cough, accelerated respiratory rate and expiratory dyspnea; serum total IgE, specific sensitized IgE levels and Th2-type inflammatory factors (IL-4, IL-5, IL-13) are significantly up-regulated compared with the blank control group. No extensive non-specific pulmonary inflammation, spontaneous lung injury or modeling-related massive animal death occurs. Successful establishment of the asthma model is confirmed, and the model stability can effectively distinguish the improvement efficacy of various interventions on airway inflammation, hyperresponsiveness and remodeling among groups.

Histomorphometric Gold-Standard Indexes

Airway histopathology of the model group shows disordered airway wall structure, damaged and exfoliated airway epithelium, mucosal congestion and edema, and massive eosinophilic and inflammatory cell infiltration; PAS staining indicates airway mucous gland hyperplasia and mucus hypersecretion; Masson staining reveals increased collagen deposition in and around the airway wall with airway wall thickening; histomorphometric indexes: airway wall thickness, collagen volume fraction and mucus secretion area ratio are significantly higher than those of the blank control group, and the number of infiltrated inflammatory cells is significantly increased, which is consistent with the typical pathological characteristics of airway inflammation and remodeling in allergic asthma without non-specific tissue damage, indicating controllable model interference.

Academic Evidence for Model Validity

The core evaluation criteria for the standardized Beagle asthma model are as follows: specific allergens induce stable Th2-type immune deviation in vivo, forming four core asthmatic pathological phenotypes including airway hyperresponsiveness, eosinophilic inflammation, mucus hypersecretion and airway collagen remodeling, and the pathological progression is highly consistent with clinical allergic asthma in children and adults. The respiratory immune response, temporal law of airway remodeling and characteristics of pulmonary function changes in Beagle dogs can truly recapitulate the acute attack and chronic persistent course of human asthma, and can objectively and quantitatively evaluate the intervention effects of various anti-asthmatic drugs, airway protective agents, targeted anti-inflammatory strategies and regenerative repair methods on asthmatic pathological injury, serving as the recognized gold-standard basis for the reliability of large-animal asthma models in translational respiratory medicine.

Model Advantages

The Beagle asthma model is the mainstream large-animal model for high-impact SCI researches in respiratory medicine, allergic diseases, airway remodeling and new drug development. Its respiratory anatomy, immune typing, inflammatory response and airway remodeling mechanism are highly homologous to humans, with far superior translational value compared with rodent models. It can stably recapitulate the whole course of asthma including immune sensitization, acute spasm, chronic inflammation, mucus proliferation and structural remodeling. It supports multiple non-invasive dynamic pulmonary function monitoring, repeated airway lavage and imaging follow-up to completely capture the temporal evolution of diseases. The modeling parameters are quantifiable with high repeatability and low intra-group variation. The complete experimental data chain realizes multi-dimensional verification of functional, imaging, histological and molecular mechanisms with high authoritative experimental results, which are easily accepted by SCI journals in respiratory and immunological fields, perfectly adapting to the research system of National Natural Science Foundation projects, fund application, proposal reports and postgraduate dissertations.

Research Applications

The Beagle Asthma Model is mainly used to systematically elucidate the complete temporal molecular mechanism of asthma including Th2-type immune deviation, airway eosinophilic inflammation, airway epithelial injury and repair, abnormal mucus secretion, airway collagen deposition and structural remodeling. It accurately evaluates the in vivo anti-inflammatory, antispasmodic, anti-remodeling and pulmonary function-improving effects and biocompatibility of various aerosol anti-asthmatic drugs, targeted anti-inflammatory agents, immune regulators, stem cell repair systems, gene targeted interventions and airway protective biomaterials. It explores the key regulatory pathways of acute asthma attack, chronic persistence and structural remodeling, and supports preclinical safety and efficacy verification of novel asthma treatment strategies and airway-targeted drug delivery systems. As a core standardized large-animal model in allergic asthma mechanism research, translational research of new respiratory drugs and airway remodeling intervention research, it fully adapts to all scientific research scenarios including project proposal, fund application, SCI paper publication and dissertation writing.

Beagle asthma model, allergic asthma, airway hyperresponsiveness, airway remodeling, airway inflammation, pulmonary function impairment, translational respiratory preclinical model